Jeito Capital Co-leads EUR 80 Million Series B Financing in European Oncology Company, Precirix

Paris, France, March 16 (Korea Bizwire) – Jeito Capital (“Jeito”), a leading independent private equity firm dedicated to biotech and biopharma, today announces that it has co-led an investment of €80 million in Precirix, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology. The Belgian biotech company was created in 2014 as a spin-off from the Vrije Universiteit [...]